Physician profile
Rachel M Knight
NPI 1194273912
$1,655.33
in general payments reported to CMS, 2019-2025
23 companies · $683 in 2025
The $683 reported for 2025 was more than what 76% of Gerontology (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $161).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.12 · 2023: $201 · 2024: $685 · 2025: $683.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,504 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,504.22 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $303.43 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $196.15 | 2023-2025 | Farxiga, Atacand, Wainua |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $166.64 | 2021-2025 | Lifevest |
| Amgen INC. | $154.83 | 2023-2025 | Repatha, Repatha |
| Bridgebio Pharma, INC. | $102.70 | 2025 | Attruby |
| Merck Sharp & Dohme LLC | $77.33 | 2025 | Verquvo, Capvaxive |
| Pfizer INC. | $76.92 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $71.28 | 2023-2025 | Camzyos, Eliquis |
| Kiniksa Pharmaceuticals International, Plc | $57.81 | 2024 | Arcalyst |
| Novo Nordisk INC | $57.17 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Irhythm Technologies, INC. | $53.64 | 2023 | Zio Xt Patch |
| Janssen Pharmaceuticals, INC | $50.60 | 2024 | Xarelto |
| Abbott Laboratories | $46.92 | 2024-2025 | Cardiomems |
| Stryker Corporation | $39.30 | 2025 | Artix Mt |
| Actelion Pharmaceuticals US, INC. | $38.05 | 2024-2025 | Opsumit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $29.10 | 2025 | Nimbl, Flexitouch Plus |
| Atricure, INC. | $25.86 | 2025 | Synergy Ablation System |
| Medtronic, INC. | $21.36 | 2024 | Corevalve Evolut R |
| Boston Scientific Corporation | $19.42 | 2024 | Watchman Access System |
| Glaxosmithkline, LLC. | $18.04 | 2025 | Shingrix |
| United Therapeutics Corporation | $17.54 | 2024 | Tyvaso |
| Esperion Therapeutics, INC. | $16.18 | 2025 | Nexletol |
| Daiichi Sankyo INC. | $15.06 | 2024 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Knight listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.